Points to consider: The importance of sameness of product in the context of regulatory reliance

Published on: 26 September 2022

In a new paper, IFPMA describes how the R&D-based pharmaceutical industry delivers products with the same quality to all countries around the world, which should facilitate  reliance procedures. IFPMA notes that mutual trust between all parties is the foundation of reliance, adding that transparency is a key principle for good regulatory practice and fundamental to reliance.